These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

685 related items for PubMed ID: 22911671

  • 1. Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review.
    dos Santos LV, Souza FH, Brunetto AT, Sasse AD, da Silveira Nogueira Lima JP.
    J Natl Cancer Inst; 2012 Sep 05; 104(17):1280-92. PubMed ID: 22911671
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of the combination neurokinin-1 receptor antagonist, palonosetron, and dexamethasone compared to others for the prophylaxis of chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials.
    Chow R, Tsao M, Chiu L, Popovic M, Milakovic M, Lam H, DeAngelis C.
    Ann Palliat Med; 2018 Apr 05; 7(2):221-233. PubMed ID: 29764184
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
    Natale JJ.
    Hosp Pract (1995); 2015 Apr 05; 43(4):226-34. PubMed ID: 26308912
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
    Navari RM.
    J Support Oncol; 2003 Apr 05; 1(2):89-103. PubMed ID: 15352652
    [Abstract] [Full Text] [Related]

  • 7. Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study.
    Llombart-Cussac A, Ramos M, Dalmau E, García-Saenz JA, González-Farré X, Murillo L, Calvo L, Morales S, Carañana V, González A, Fernández-Morales LA, Moreno F, Casas MI, Angulo Mdel M, Cámara MC, Garcia-Mace AI, Carrasco E, Jara-Sánchez C.
    Eur J Cancer; 2016 May 05; 58():122-9. PubMed ID: 26994459
    [Abstract] [Full Text] [Related]

  • 8. Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting: A Network Meta-Analysis.
    Zhang Y, Yang Y, Zhang Z, Fang W, Kang S, Luo Y, Sheng J, Zhan J, Hong S, Huang Y, Zhou N, Zhao H, Zhang L.
    J Natl Cancer Inst; 2017 Feb 05; 109(2):. PubMed ID: 27795228
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Emerging drugs for chemotherapy-induced emesis.
    Navari RM, Province PS.
    Expert Opin Emerg Drugs; 2006 Mar 05; 11(1):137-51. PubMed ID: 16503832
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy.
    Hesketh PJ, Schnadig ID, Schwartzberg LS, Modiano MR, Jordan K, Arora S, Powers D, Aapro M.
    Cancer; 2016 Aug 01; 122(15):2418-25. PubMed ID: 27176138
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of palonosetron versus other serotonin 5-HT3 receptor antagonists in triple antiemetic regimens during multiday highly emetogenic chemotherapy.
    Kim KI, Lee DE, Cho I, Yoon JH, Yoon SS, Lee HS, Oh JM.
    Ann Pharmacother; 2012 Dec 01; 46(12):1637-44. PubMed ID: 23170032
    [Abstract] [Full Text] [Related]

  • 16. Palonosetron for prevention of delayed chemotherapy-induced nausea and vomiting in pediatric patients: a meta-analysis.
    Yamaguchi A, Saito Y, Takekuma Y, Sugawara M.
    Support Care Cancer; 2023 Dec 26; 32(1):58. PubMed ID: 38145979
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of olanzapine, neurokinin-1 receptor antagonists, and thalidomide in combination with palonosetron plus dexamethasone in preventing highly emetogenic chemotherapy-induced nausea and vomiting: a Bayesian network meta-analysis.
    Alhifany AA, McBride A, Almutairi AR, Cheema E, Shahbar A, Alatawi Y, Alharbi AS, Babiker H, MacDonald K, Aapro M, Abraham I.
    Support Care Cancer; 2020 Mar 26; 28(3):1031-1039. PubMed ID: 31823054
    [Abstract] [Full Text] [Related]

  • 18. Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.
    Phillips RS, Friend AJ, Gibson F, Houghton E, Gopaul S, Craig JV, Pizer B.
    Cochrane Database Syst Rev; 2016 Feb 02; 2(2):CD007786. PubMed ID: 26836199
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Prophylaxis of chemotherapy-induced vomiting and nausea].
    Tóth J, Szántó J.
    Magy Onkol; 2008 Dec 02; 52(4):391-4. PubMed ID: 19068468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.